Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
If you are past the initial phase, have reached your target weight or a stable maintenance phase, and want to reduce frequency, discuss it with your provider
DHEA and DHEAS appear to counteract the negative effects of increased cortisol on working memory function in women and men, respectively (315, 316)
But to do that, we need lower prices, thoughtful coverage policies, and a clearer understanding of who benefits most. Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults was published in JAMA Health Forum in March 2025
In conclusion, our data suggest that the treatment with the antioxidant peptide Epitalon enhanced impaired wound healing processes in HG-injured ARPE-19 cells by inhibiting hyperglycemia-induced EMT and fibrosis, thus supporting the therapeutic benefits of this interesting peptide for DR management
Beltramello, M
